Inovio Pharmaceuticals Inc (NAS:INO)
$ 11.11 -0.89 (-7.42%) Market Cap: 287.87 Mil Enterprise Value: 218.74 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 48/100

Q3 2023 Inovio Pharmaceuticals Inc Earnings Call Transcript

Nov 09, 2023 / 09:30PM GMT
Release Date Price: $4.35 (-4.71%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Inovio third-quarter 2023 financial results conference call. (Operator Instructions) This call is being recorded on Thursday, November 9, 2023. And I would now like to turn the conference over to Mr. Thomas Hong. Thank you. Please go ahead.

Thomas Hong
Inovio Pharmaceuticals, Inc. - IR

Good afternoon and thank you for joining the Inovio 2023 third-quarter conference call. Joining me on today's call are Dr. Jacqui Shea, President and CEO; Dr. Michael Sumner, Chief Medical Officer; Mr. Mark Twyman, Chief Commercial Officer; and Mr. Peter Kies, Chief Financial Officer.

Today's call will review our corporate and financial information for the quarter ended September 30, 2023, as well as provide a development progress update for our DNA medicines platform. Following prepared remarks, we will conduct a question-and-answer segments.

During the call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot